MedPath

Paraplegia Prevention in Aortic Aneurysm Repair by Thoracoabdominal Staging with Minimally-Invasive Staged Segmental Artery Coil-Embolization: A Randomized Controlled Multicentre Trial

Phase 2
Conditions
Thoracoabdominal aortic aneurysm
Registration Number
DRKS00029921
Lead Sponsor
niversitätsklinikum Leipzig
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
750
Inclusion Criteria

TAAA, Crawford types I, II or III or type B dissections of comparable extent; planned open or endovascular repair of aneurysm within four months; > 18 years old

Exclusion Criteria

complicated acute type B aortic dissection; emergencies; untreated aortic arch aneurysm; bilaterally occluded iliac arteries or chronic total occlusion of left subclavian artery; pre-operative neurological deficits or spinal cord dysfunction; major untreated cardio-pulmonary disease; life-expectancy of less than one year; high risk for segmental artery embolism; severe contrast agent allergy, severe reduction in glomerular filtration rate; expected lack of compliance; pregnant or nursing women; impaired thyroid function, if not under stable treatment; women of child bearing potential without highly effective contraceptive measures; current participation in other interventional clinical trial

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary objective is to greatly reduce incidence of ischaemic spinal cord injury and mortality - the most devastating complications resulting from aneurysm repair.
Secondary Outcome Measures
NameTimeMethod
The secondary objective of the trial will focus on further potential treatment advantages and/or risks of the MISACE-procedure (Minimally-Invasive Staged Segmental Artery Coil-Embolization).
© Copyright 2025. All Rights Reserved by MedPath